Looking for further pathway components shuttled via EVs, also the active TGF‐β type II receptor has been described to shuttle between stromal fibroblasts and squamous carcinoma cells influencing TGF‐β signaling in the tumor–stroma interaction [99]. Here, TGFB1 is linked to neoplasm.